The Weighty Issues

Out of the ashes of 9/11...US Never Forgets...INDIA Forgives!!!!

When you are weak in all the respects, troubled with corruption and spineless leadership you have no way out but to forgive !!!
Out of the ashes of 9/11 comes a ship forged from the steel of theWorld Trade Center!

HERE SHE IS - the USS New York, Made from the World Trade Center!!

It was built with 24 tons of scrap steel from the World Trade Center.

It is the fifth in a new class of warship - designed for missions that include special operations against terrorists. It will carry a crew of 360 sailors and 700 combat-ready Marines to be delivered ashore by helicopters and assault craft.

Steel from the World Trade Center was melted down in a foundry in Amite, LA to cast the ship's bow section.. When it was poured into the moulds on Sept 9, 2003, 'those big rough steelworkers treated it with total reverence,' recalled Navy Capt. Kevin Wensing, who was there. 'It was a spiritual moment for everybody there.'

Junior Chavers, foundry operations manager, said that when the trade center steel first arrived, he touched it with his hand and the 'hair on my neck stood up..' 'It had a big meaning to it for all of us,' he said. 'They knocked us down.. They can't keep us down. We're going to be back.'

The ship's title? 'Never Forget'

Mummy tummies the shape of things to come

Bronzed and beautiful, mums-to-be are throwing off the maternity garb and celebrating their baby bumps.
And women who have gone through an arduous journey with IVF are the latest fans of belly casting.
Nicole Shulman, co-owner of Melbourne business Belly Art, said these women in particular were keen to document every moment of their pregnancies.
"In the past two years we have been getting a lot of people who have gone through a long journey with IVF," Ms Shulman said.
"They have tried so hard for so long to get pregnant that they want to immortalise every step.
"For other people, they might have had three children and realise this is their last time being pregnant."
The business, which has been casting pregnant bellies for eight years, says the latest trend is a bronze finish plaster cast. And the bigger the bump, the better.
While many women would rather hide under a rock than show off their pregnant figure, Ms Shulman said women were waiting until as late as 40 weeks to be cast.
"Thankfully no one has given birth yet while we've been doing it," she said.
"The bronze ones look more like a sculptural piece."
They are hung as art on walls, children's rooms, in offices and even cafes, but Ms Shulman admits they are not to everyone's taste.
Mother of two Miranda Caciolo, 37, was so keen to preserve her pregnant shape she was cast from her thighs to her neck.
"If you are confident about your body, it should be something to show off," she said.
"I think I had a great shape when I was pregnant."

Classic Peanuts Still Rules!

Scientific breakthrough as red blood cells are made from IVF embryos

British scientists have turned stem cells from spare IVF embryos into red blood cells as part of a project to manufacture synthetic blood on an industrial-scale. It is believed to be the first time in Britain that human red blood cells have been created from embryonic stem cells and it marks a milestone in a project aimed at producing blood for medical transfusions.

The aim of the £3m project is to develop an alternative source of O-negative blood, the universal donor group that can be transfused into the vast majority of the population without fear of rejection. The project, funded by the Wellcome Trust, has used more than a hundred spare IVF embryos from fertility clinics to establish several embryonic stem cell lines that replicate continuously in the laboratory. One of these lines, known as RC-7, has been transformed from embryonic cells into blood stem cells before being converted into the functioning red blood cells that contain the oxygen-carrying pigment haemoglobin.

Professor Marc Turner, the director of the Scottish National Blood Transfusion Service in Edinburgh and leader of the project, said that synthetic blood made on an industrial scale would overcome the problem of blood shortages and the risk of transmitting new infections between donors and recipients. "We've proved the principle that from these embryonic stem cell lines we can generate red blood cells," Professor Turner said. "At the end of this three-year period we would envisage generating up to a unit [a pint] of red cells from embryonic stem cells at clinical grade which fulfil all the in vitro characteristics of red cells."

If all goes to plan, the first clinical trials of synthetic blood made from embryonic stem cells could begin within five years. The aim then is to scale-up the manufacturing process to produce more than two million pints a year using industrial bio-reactors.

It would raise the possibility of producing the entire supply of blood for the UK from a single "universal blood donor" who only ever existed as a four-day-old IVF embryo.

However, there are still obstacles to overcome. The scientists have to show, for instance, that the embryonic stem cells are cultured with laboratory reagents that have not been in contact with animal cells, which would risk contamination with animal diseases.

"The regulators, the Medicines and Healthcare Products Regulatory Agency and the European Medicines Agency, would need to be comfortable that the cells were produced to sufficient quality and safety before they would allow the first studies in humans," Professor Turner said.

As part of the process of gaining regulatory approval, the project has produced four embryonic stem cell lines deemed good enough to be used in human clinical trials – conforming to the "good manufacturing practice" (GMP) grade. They have been made by Roslin Cells, a spin-off company from the Roslin Institute in Edinburgh where Dolly the sheep was cloned.

Jo Mountford, a stem cell scientist at Glasgow University, confirmed that the synthetic red cells made in her laboratory from the RC-7 embryonic stem cell line produced by Roslin Cells contained the haemoglobin pigment. "We have cells that are clearly red so we're happy with that. We've managed to go 90 per cent down the path towards fully differentiated, adult red blood cells," Dr Mountford said.

One problem still to be resolved is to get the synthetic red cells to eject their nuclei, as happens naturally. This enables the cells to carry oxygen more efficiently and to pass through the narrow capillaries of the blood vessels.

Dr Mountford said that the haemoglobin in the synthetic red cells also shows signs of being more similar to foetal than adult haemoglobin, but she believes that further research will lead to mature, enucleated red blood cells with adult haemoglobin. "We're confident that we'll get the numbers of mature red blood cells that we need for clinical trials," she said.

Only one of the four embryonic stem cells lines produced at GMP grade has been tested for its blood type, Professor Turner said. The line, known as RC-9, is blood type B-positive and although it is not the universal donor type it can still be used for research.

The work on red cells is being watched with interest by researchers trying to convert embryonic stem cells into other specialised tissues. In many ways, red blood cells pose fewer problems than nerve, muscle or liver cells which contain cell nuclei and carry the risk of becoming cancerous, Professor Turner said. "If we can crack it with red cells, it takes us a long way. It doesn't solve it with other tissues but it takes us a long way to cracking it with other tissues, such as liver and so on."

A key requirement for synthetic blood is that it should be just as cheap, or cheaper, to produce than donated blood. It currently costs about £180 to make a pint of donated blood ready for transfusion, but the extra costs associated with testing and donation bring the total figure to about £500 per pint.

Chinese Digits

This Chinese boy has 34 fingers & toes. Now he has to undergo a surgery to remove extra digits.The previous world record was 25 digits.

Majority of women support single woman using IVF treatment to conceive, survey finds

Women feel strongly about their ability to conceive.

A recent survey of American women aged 25-45 that gauged attitudes toward In Vitro Fertilization (IVF) found that 83% of these women support a single woman using IVF to conceive if she is emotionally and financially able to care for the child.

The survey of 1,936 American women was conducted in June 2010 by Barbados Fertility Centre and Ipsos Reid. Barbados Fertility Centre is a destination for a growing number of American women and couples who want to undergo fertility treatment for half the cost of what they would pay in the US without compromising success rates.

"We have seen a sharp increase in patients and inquiries from all backgrounds in the United States, including heterosexual and gay single women and couples, so we wanted to better understand how American women view IVF," said Dr. Juliet Skinner, Medical Director of Barbados Fertility Centre, located in Barbados, in the Southern Caribbean. "Not only did we find overwhelming support for IVF for single women, but we learned that most women considering IVF are willing to travel to receive it if there is a cost-effective alternative that provides exceptional care."

Key Survey Findings: - Over one quarter of American women aged 25-45 (28%) who are planning to have a child are concerned about their ability to conceive. - Most surveyed (57%) were unwilling to travel outside of the US for any kind of medical procedure. However, fully 74% of women aged 25-45 who would consider IVF would be willing to travel outside of the US for the procedure if there was a significantly lower cost and higher pregnancy success rate. - 57% of women who plan to have a child, or are currently unsure, are likely to consider IVF.

Added Dr. Skinner, "the ability to have a child, whether in a couple or alone, is something women feel very strongly about and want to have as many options as possible available to them. This includes freezing their eggs, IVF treatment and travelling for more affordable, effective treatments."

The high cost of IVF treatment in the US, particularly in California and New York where costs are the highest, has created greater demand among American patients for services at Barbados Fertility Centre. The average cost of IVF in the US is $14,000 USD for one treatment cycle alone. In contrast, Americans travelling to Barbados pay an average of $5,750 USD, which is less than half the cost of receiving treatment at home. Even with the travel and medication costs factored in, the entire cost of the procedure is still significantly lower due to the rising costs of healthcare services in the US.